Foley & Lardner jumped up two spots on this year’s “Am Law 100” and is now ranked as the 46th largest firm based on gross revenues.
The American Lawyer reported gross revenues for the firm of $920,427,000 for the last fiscal year, a 10 percent increase over the previous year.
The American Lawyer’s “Am Law 100” feature analyzes the financial health of the nation’s 100 largest law firms by self-reported gross revenue and other key metrics.
Among other “Am Law 100” members, Foley is ranked:
- 61st based on 2019 compensation to all partners
- 58rd based 2019 revenue per lawyer
- 61st based on 2019 profits per lawyer
For complete details, metric and calculations, read “The 2020 Am Law 100” (subscription required).
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”